Van Berkom & Associates Inc. Reduces Stake in HealthEquity, Inc. (NASDAQ:HQY)

Van Berkom & Associates Inc. reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 10.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 838,321 shares of the company’s stock after selling 97,260 shares during the period. HealthEquity comprises 2.4% of Van Berkom & Associates Inc.’s investment portfolio, making the stock its 20th biggest position. Van Berkom & Associates Inc. owned approximately 0.97% of HealthEquity worth $80,437,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of HQY. Wasatch Advisors LP grew its holdings in HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the period. State Street Corp increased its holdings in HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after acquiring an additional 23,613 shares during the last quarter. Geode Capital Management LLC raised its stake in HealthEquity by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after acquiring an additional 15,145 shares during the period. Franklin Resources Inc. lifted its holdings in HealthEquity by 0.7% during the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock valued at $139,369,000 after purchasing an additional 11,659 shares during the last quarter. Finally, Loomis Sayles & Co. L P lifted its holdings in HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after purchasing an additional 24,665 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on HQY shares. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. JMP Securities boosted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Barrington Research boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $110.71.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Trading Down 1.8 %

Shares of HealthEquity stock opened at $111.72 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The firm has a market cap of $9.68 billion, a PE ratio of 102.50, a PEG ratio of 1.62 and a beta of 0.55. The company has a 50 day simple moving average of $103.40 and a two-hundred day simple moving average of $91.77.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the company earned $0.40 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.